Collectively, in either p53-wt HPNE normal cells or p53-mutant CD18/HPAF cancer cells, senescence induction in response to IR requires a low level of PR55α expression, thereby revealing PR55α as a potent inhibitor of IR-induced cellular senescence. The gene discussed is TP53; the disease is cancer.